Implanet, in a press statement, announced FDA 510 (k) clearance for the Squale anterior cervical cradle.
According to a release, Squale anterior cages are available with a wide range of implants designed to match the vertebral morphology of patients undergoing procedures for interbody fusion.
“This new clearance demonstrates once again the full potential of the synergies offered by the range of products in the [orthopedic and spine development] portfolio and is fully in line with our strategy to revitalize our presence in the United States,” Ludovic Lastennet, CEO of Implanet, said in the
He Returned to the US for His Daughter’s Wedding. He was left with a $42,000 bill for hospitalization.